Deal facts
- Buyer
- Telomir Pharmaceuticals, Inc.
- Target
- TELI Pharmaceuticals, Inc.
- Deal value
- USD 34,389,710
- Announced
- 22 April 2026
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- shares
Sources
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Telomir Pharmaceuticals, Inc. completes acquisition of TELI Pharmaceuticals, Inc.
Item 1.01. Entry into a Material Definitive Agreement On April 22, 2026, Telomir Pharmaceuticals, Inc. (the “Company”) completed its acquisition of TELI Pharmaceuticals, Inc. (“TELI”) pursuant to the previously announced merger agreement (the “Transaction”). The Transaction was previously approved by the Company’s shareholders during the Company’s annual shareholders meeting on March 23, 2026. At
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business
Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…
- Buyer
- Dolby Medical Home Respiratory Care Limited (Vivisol)
- Target
- Air Liquide Healthcare Limited’s home oxygen services business
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
RSLGH, LLC to acquire RYTHM, Inc.
RSLGH, LLC has agreed to acquire RYTHM, Inc., a healthcare company based in the United States, in a strategic acquisition valued at $109.5 million. The transaction invol…
- Buyer
- RSLGH, LLC
- Target
- RYTHM, Inc.
- Deal value
- USD 109,500,000
- Deal type
- strategic acquisition
Ensysce Biosciences, Inc. to acquire Cy Biopharma, Inc.
Ensysce Biosciences, Inc. has agreed to acquire Cy Biopharma, Inc. in a strategic acquisition within the healthcare sector. The transaction was announced on 5 August 202…
- Buyer
- Ensysce Biosciences, Inc.
- Target
- Cy Biopharma, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Profusa, Inc. to acquire G3 Vision Labs Inc.
Profusa, Inc. has agreed to acquire G3 Vision Labs Inc. in a strategic acquisition within the healthcare sector. The transaction involves the exchange of shares as the p…
- Buyer
- Profusa, Inc.
- Target
- G3 Vision Labs Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Telomir Pharmaceuticals, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive